Association of testosterone with estrogen abolishes the beneficial effects of estrogen treatment by increasing ROS generation in aorta endothelial cells.

Testosterone has been added to hormone replacement therapy to treat sexual dysfunction in postmenopausal women. Whereas estrogen has been associated with vascular protection, the vascular effects of testosterone are contradictory and the effects of its association with estrogen are largely unknown. In this study we determined the effects of testosterone associated with conjugated equine estrogen (CEE) on vascular function using a model of hypertensive postmenopausal female: ovariectomized spontaneously hypertensive rats. Female spontaneously hypertensive rats were divided into sham-operated, ovariectomized (OVX), and OVX treated for 15 days with either CEE alone (OVX+CEE) or associated with testosterone (OVX+CEE+T). Angiotensin II (ANG II)-induced contraction was markedly increased in aortic rings from OVX compared with sham-operated rats. CEE treatment restored ANG-II responses, a beneficial effect abrogated with CEE+T. CEE treatment also increased endothelium-dependent relaxation, which was impaired in OVX rats. This effect was lost by CEE+T. Treatment of aortas with losartan (ANG-II type-1 receptor antagonist) or apocynin (NADPH-oxidase inhibitor) restored the endothelium-dependent relaxation in OVX and CEE+T, establishing an interplay between ANG-II and endothelial dysfunction in OVX and CEE+T. The benefits by CEE were associated with downregulation of NADPH-oxidase subunits mRNA expression and decreased reactive oxygen species generation. The association of testosterone with CEE impairs the benefits of estrogen on OVX-associated endothelial dysfunction and reactive oxygen species generation in rat aorta by a mechanism that involves phosphorylation of the cytosolic NADPH-oxidase subunit p47(phox).

[1]  E. Vila,et al.  Western-type diet induces senescence, modifies vascular function in non-senescence mice and triggers adaptive mechanisms in senescent ones , 2013, Experimental Gerontology.

[2]  Z. Fortes,et al.  Conjugated equine estrogen treatment corrected the exacerbated aorta oxidative stress in ovariectomized spontaneously hypertensive rats , 2013, Steroids.

[3]  C. Hermenegildo,et al.  Effects of Estrogen on Vascular Inflammation: A Matter of Timing , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[4]  R. Touyz,et al.  Testosterone Induces Vascular Smooth Muscle Cell Migration by NADPH Oxidase and c-Src–Dependent Pathways , 2012, Hypertension.

[5]  A. N. McLendon,et al.  Testosterone Supplementation for Hypoactive Sexual Desire Disorder in Women , 2012, Pharmacotherapy.

[6]  F. Iellamo,et al.  Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. , 2010, Journal of the American College of Cardiology.

[7]  M. Pastor,et al.  Equine Estrogens Impair Nitric Oxide Production and Endothelial Nitric Oxide Synthase Transcription in Human Endothelial Cells Compared With the Natural 17&bgr;-Estradiol , 2010, Hypertension.

[8]  K. Griendling,et al.  NADPH Oxidases: Functions and Pathologies in the Vasculature , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[9]  K. Fukunaga,et al.  Characterization of an animal model of postmenopausal cardiac hypertrophy and novel mechanisms responsible for cardiac decompensation using ovariectomized pressure-overloaded rats , 2010, Menopause.

[10]  M. Barton,et al.  Postmenopausal hypertension: mechanisms and therapy. , 2009, Hypertension.

[11]  J. Morley,et al.  The benefits and risks of testosterone replacement therapy: a review , 2009, Therapeutics and clinical risk management.

[12]  M. Gougerot-Pocidalo,et al.  p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases , 2009, Experimental & Molecular Medicine.

[13]  G. Braunstein,et al.  Testosterone for low libido in postmenopausal women not taking estrogen. , 2008, The New England journal of medicine.

[14]  R. Iliescu,et al.  Sex Differences in the Pressor Response to Angiotensin II When the Endogenous Renin-Angiotensin System Is Blocked , 2008, Hypertension.

[15]  D. Deecher,et al.  Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages , 2007, Archives of Women's Mental Health.

[16]  R. Davies,et al.  The impact of hormone replacement therapy on the pathophysiology of peripheral arterial disease. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  A. Stensballe,et al.  A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. , 2006, The Journal of clinical investigation.

[18]  L. Hunyady,et al.  Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. , 2006, Molecular endocrinology.

[19]  V. Miller,et al.  Differential Effects of Chronic Treatment with Estrogen Receptor Ligands on Regulation of Nitric Oxide Synthase in Porcine Aortic Endothelial Cells , 2006, Journal of cardiovascular pharmacology.

[20]  L. Dennerstein,et al.  Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. , 2006, The journal of sexual medicine.

[21]  N. Watts,et al.  Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. , 2006, Archives of internal medicine.

[22]  R. Rosen,et al.  Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS) , 2006, Menopause.

[23]  E. Jackson,et al.  Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. , 2005, Cardiovascular research.

[24]  J. Reckelhoff.  Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations. , 2005, Hypertension.

[25]  L. Ignarro,et al.  Estrogen-related receptor α1 up-regulates endothelial nitric oxide synthase expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Z. Fortes,et al.  Effects of estrogen on the vascular system. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[27]  R. Clempus,et al.  Vascular NAD(P)H oxidases: specific features, expression, and regulation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[29]  W. Edwards,et al.  Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[31]  Toulouse,et al.  Estradiol Alters Nitric Oxide Production in the Mouse Aorta Through the α-, but not β-, Estrogen Receptor , 2002 .

[32]  Z. Fortes,et al.  In Vivo Evidence for Antioxidant Potential of Estrogen in Microvessels of Female Spontaneously Hypertensive Rats , 2002, Hypertension.

[33]  J F Reckelhoff,et al.  Gender Differences in the Regulation of Blood Pressure , 2001, Hypertension.

[34]  G. Nickenig,et al.  Endothelial Dysfunction and Oxidative Stress During Estrogen Deficiency in Spontaneously Hypertensive Rats , 2001, Circulation.

[35]  J. Delgado,et al.  17beta-estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  Orman,et al.  Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. , 2000, The New England journal of medicine.

[37]  R. Baker,et al.  Premarin-induced increases in coronary and uterine blood flow in nonpregnant sheep. , 2000, American journal of obstetrics and gynecology.

[38]  R S Reneman,et al.  In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. , 2000, American journal of physiology. Heart and circulatory physiology.

[39]  Z. Fortes,et al.  Influence of female sex hormones on endothelium-derived vasoconstrictor prostanoid generation in microvessels of spontaneously hypertensive rats. , 1999, Hypertension.

[40]  P. Ramwell,et al.  Effect of Testosterone Treatment on Vasoconstrictor Response of Left Anterior Descending Coronary Artery in Male and Female Pigs , 1995, Journal of cardiovascular pharmacology.

[41]  Z. Fortes,et al.  Reactivity of aorta and mesenteric microvessels to drugs in spontaneously hypertensive rats: role of the endothelium. , 1987, Journal of hypertension.

[42]  T. Lüscher,et al.  Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. , 1986, Hypertension.

[43]  Dongye Li,et al.  Testosterone enhances estradiol's cardioprotection in ovariectomized rats. , 2012, The Journal of endocrinology.

[44]  M. Irahara,et al.  Androgen in postmenopausal women. , 2012, The journal of medical investigation : JMI.

[45]  J. McNeill,et al.  Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats , 2011, Molecular and Cellular Biochemistry.

[46]  A. Camargos,et al.  Effects of simultaneous treatment with estrogen and testosterone on the uterus of female adult rats. , 2007, Clinical and experimental obstetrics & gynecology.

[47]  K. Griendling,et al.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.

[48]  M. Franco,et al.  Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. , 2004, Cardiovascular research.

[49]  L. Ignarro,et al.  Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Chambon,et al.  Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. , 2002, Circulation research.

[51]  J. Granger,et al.  Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. , 1998, Hypertension.

[52]  P. Kadowitz,et al.  Effects of 17 beta-estradiol on endothelium-dependent relaxation induced by acetylcholine in female rat aorta. , 1994, Life sciences.